Literature DB >> 17037269

Fallback tests in dose-response clinical trials.

Alex Dmitrienko1, Brian Wiens, Peter Westfall.   

Abstract

This article introduces a general testing procedure for performing dose-control comparisons in dose-response trials with one or more endpoints. The procedure (termed multi-stage fallback procedure) is an extension of the fallback test proposed by Wiens (2003). The multi-stage fallback procedure features a simple stepwise form and improves the power of dose-control tests at higher doses by taking into account the ordering of the doses. It also serves as an efficient tool for handling multiplicity caused by multiple endpoints. It is shown in this article that the multi-stage fallback procedure can be formulated as a closed testing procedure and thus controls the Type I error rate with respect to multiple dose-control comparisons as well as multiple endpoints. The proposed testing method is illustrated using examples from dose-response clinical trials with single and multiple endpoints.

Mesh:

Substances:

Year:  2006        PMID: 17037269     DOI: 10.1080/10543400600860600

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  1 in total

1.  Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.

Authors:  Bettina Kulle Andreassen; Nathalie C Støer; Jan Ivar Martinsen; Giske Ursin; Elisabete Weiderpass; G Hege Thoresen; Karen Boldingh Debernard; Øystein Karlstad; Anton Pottegard; Søren Friis
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.